Global Probiotics for Infants and Women Market Research Report 2026

Probiotics for Infants and Women Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Probiotics for Infants and Women competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

In the 21st century, advances in technologies such as genetic sequencing have greatly accelerated gut microbiome research. As a result, our understanding of the health benefits and mechanisms of probiotics has become more comprehensive. Probiotics—live microorganisms that are generally recognized as beneficial to the host—have emerged as one of the most prominent applied categories in life sciences. For infants, probiotics help quickly establish and maintain a healthy gut microbiota. The two major families of probiotics are Lactobacillus and Bifidobacterium. While Lactobacillus functions similarly in both adults and infants, Bifidobacterium plays a particularly crucial role in early childhood. In women’s health, probiotic research primarily focuses on preventing and treating vaginitis and improving health during pregnancy and postpartum. Today, probiotics attract significant attention across ordinary foods, health supplements, and pharmaceuticals. This report focuses on probiotic powder ingredients for infants and women.

The market for probiotics tailored to infants and women is currently experiencing rapid growth. Rising health awareness and increasing consumer preference for natural and functional products are driving demand. In the maternal and infant product categories, probiotics have become a key functional ingredient, commonly added to infant formula, complementary foods, and probiotic drops. In women’s health, probiotics are increasingly used in dietary supplements aimed at improving reproductive health and regulating the gut microbiota. The probiotic raw powder segment, as a critical upstream component, has attracted strong attention from both domestic and international brands. Market players include traditional fermentation enterprises, biotech firms, and multinational health companies, contributing to an increasingly competitive landscape. With continued progress in basic research, accumulation of clinical evidence, and ongoing consumer education, the probiotics market for infants and women is expected to evolve toward greater specialization and precision. Future products will emphasize clearly defined probiotic strains supported by scientific validation. Personalized nutrition solutions and scenario-specific product designs will become major development directions. Regulatory frameworks will also become more rigorous, pushing the industry from a concept-driven to a standard- and evidence-based model. Moreover, innovative delivery systems (such as time-release capsules and smart microencapsulation) and combination formulations (such as synbiotics) will enhance product form and user experience. Key market drivers include the broader trend of upgraded health consumption, the rigid demand among specific groups such as infants and women, and the growing acceptance of microbiome science in both medical and wellness contexts. Ongoing innovation and sustained industry investment are also injecting momentum into the sector. However, the industry still faces significant challenges, such as inconsistent consumer understanding of probiotic benefits, lack of standardized strain efficacy data, variability in raw material quality, and issues with misleading marketing and regulatory gaps. These factors undermine product credibility and market penetration, posing obstacles to future growth.

This report delivers a comprehensive overview of the global Probiotics for Infants and Women market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Probiotics for Infants and Women. The Probiotics for Infants and Women market size, estimates, and forecasts are provided in terms of sales volume (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Probiotics for Infants and Women market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Probiotics for Infants and Women manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Probiotics for Infants and Women Market Report

Chapter Outline

1.1 Product Definition

1.2 Probiotics for Infants and Women by Type

1.2.1 Global Probiotics for Infants and Women Market Value by Type: 2025 vs 2032

1.2.2 Lactobacillus

1.2.3 Bifidobacterium

1.2.4 Others

1.3 Probiotics for Infants and Women by Application

1.3.1 Global Probiotics for Infants and Women Market Value by Application: 2025 vs 2032

1.3.2 Infant

1.3.3 Women

1.4 Global Probiotics for Infants and Women Market Size Estimates and Forecasts

1.4.1 Global Probiotics for Infants and Women Revenue 2021–2032

1.4.2 Global Probiotics for Infants and Women Sales 2021–2032

1.4.3 Global Probiotics for Infants and Women Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2.1 Global Probiotics for Infants and Women Sales Market Share by Manufacturers (2021–2026)

2.2 Global Probiotics for Infants and Women Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Probiotics for Infants and Women Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Probiotics for Infants and Women, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Probiotics for Infants and Women, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Probiotics for Infants and Women, Product Types and Applications

2.7 Global Key Manufacturers of Probiotics for Infants and Women, Date of Entry into the Industry

2.8 Global Probiotics for Infants and Women Market Competitive Situation and Trends

2.8.1 Global Probiotics for Infants and Women Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Probiotics for Infants and Women Players Market Share by Revenue

2.8.3 Global Probiotics for Infants and Women Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Probiotics for Infants and Women Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Probiotics for Infants and Women Sales by Region: 2021–2032

3.2.1 Global Probiotics for Infants and Women Sales by Region: 2021–2026

3.2.2 Global Probiotics for Infants and Women Sales by Region: 2027–2032

3.3 Global Probiotics for Infants and Women Revenue by Region: 2021–2032

3.3.1 Global Probiotics for Infants and Women Revenue by Region: 2021–2026

3.3.2 Global Probiotics for Infants and Women Revenue by Region: 2027–2032

3.4 North America Probiotics for Infants and Women Market Facts & Figures by Country

3.4.1 North America Probiotics for Infants and Women Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Probiotics for Infants and Women Sales by Country (2021–2032)

3.4.3 North America Probiotics for Infants and Women Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Probiotics for Infants and Women Market Facts & Figures by Country

3.5.1 Europe Probiotics for Infants and Women Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Probiotics for Infants and Women Sales by Country (2021–2032)

3.5.3 Europe Probiotics for Infants and Women Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Probiotics for Infants and Women Market Facts & Figures by Region

3.6.1 Asia Pacific Probiotics for Infants and Women Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Probiotics for Infants and Women Sales by Region (2021–2032)

3.6.3 Asia Pacific Probiotics for Infants and Women Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Probiotics for Infants and Women Market Facts & Figures by Country

3.7.1 Latin America Probiotics for Infants and Women Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Probiotics for Infants and Women Sales by Country (2021–2032)

3.7.3 Latin America Probiotics for Infants and Women Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Probiotics for Infants and Women Market Facts & Figures by Country

3.8.1 Middle East and Africa Probiotics for Infants and Women Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Probiotics for Infants and Women Sales by Country (2021–2032)

3.8.3 Middle East and Africa Probiotics for Infants and Women Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Probiotics for Infants and Women Sales by Type (2021–2032)

4.1.1 Global Probiotics for Infants and Women Sales by Type (2021–2026)

4.1.2 Global Probiotics for Infants and Women Sales by Type (2027–2032)

4.1.3 Global Probiotics for Infants and Women Sales Market Share by Type (2021–2032)

4.2 Global Probiotics for Infants and Women Revenue by Type (2021–2032)

4.2.1 Global Probiotics for Infants and Women Revenue by Type (2021–2026)

4.2.2 Global Probiotics for Infants and Women Revenue by Type (2027–2032)

4.2.3 Global Probiotics for Infants and Women Revenue Market Share by Type (2021–2032)

4.3 Global Probiotics for Infants and Women Price by Type (2021–2032)

5.1 Global Probiotics for Infants and Women Sales by Application (2021–2032)

5.1.1 Global Probiotics for Infants and Women Sales by Application (2021–2026)

5.1.2 Global Probiotics for Infants and Women Sales by Application (2027–2032)

5.1.3 Global Probiotics for Infants and Women Sales Market Share by Application (2021–2032)

5.2 Global Probiotics for Infants and Women Revenue by Application (2021–2032)

5.2.1 Global Probiotics for Infants and Women Revenue by Application (2021–2026)

5.2.2 Global Probiotics for Infants and Women Revenue by Application (2027–2032)

5.2.3 Global Probiotics for Infants and Women Revenue Market Share by Application (2021–2032)

5.3 Global Probiotics for Infants and Women Price by Application (2021–2032)

6.1 DuPont

6.1.1 DuPont Company Information

6.1.2 DuPont Description and Business Overview

6.1.3 DuPont Probiotics for Infants and Women Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 DuPont Probiotics for Infants and Women Product Portfolio

6.1.5 DuPont Recent Developments/Updates

6.2 Novonesis

6.2.1 Novonesis Company Information

6.2.2 Novonesis Description and Business Overview

6.2.3 Novonesis Probiotics for Infants and Women Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Novonesis Probiotics for Infants and Women Product Portfolio

6.2.5 Novonesis Recent Developments/Updates

6.3 Lallemand

6.3.1 Lallemand Company Information

6.3.2 Lallemand Description and Business Overview

6.3.3 Lallemand Probiotics for Infants and Women Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Lallemand Probiotics for Infants and Women Product Portfolio

6.3.5 Lallemand Recent Developments/Updates

6.4 BioGaia

6.4.1 BioGaia Company Information

6.4.2 BioGaia Description and Business Overview

6.4.3 BioGaia Probiotics for Infants and Women Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 BioGaia Probiotics for Infants and Women Product Portfolio

6.4.5 BioGaia Recent Developments/Updates

6.5 Probi

6.5.1 Probi Company Information

6.5.2 Probi Description and Business Overview

6.5.3 Probi Probiotics for Infants and Women Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Probi Probiotics for Infants and Women Product Portfolio

6.5.5 Probi Recent Developments/Updates

6.6 Biosearch Life

6.6.1 Biosearch Life Company Information

6.6.2 Biosearch Life Description and Business Overview

6.6.3 Biosearch Life Probiotics for Infants and Women Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Biosearch Life Probiotics for Infants and Women Product Portfolio

6.6.5 Biosearch Life Recent Developments/Updates

6.7 Morinaga Milk Industry

6.7.1 Morinaga Milk Industry Company Information

6.7.2 Morinaga Milk Industry Description and Business Overview

6.7.3 Morinaga Milk Industry Probiotics for Infants and Women Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Morinaga Milk Industry Probiotics for Infants and Women Product Portfolio

6.7.5 Morinaga Milk Industry Recent Developments/Updates

6.8 Synbio Tech

6.8.1 Synbio Tech Company Information

6.8.2 Synbio Tech Description and Business Overview

6.8.3 Synbio Tech Probiotics for Infants and Women Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Synbio Tech Probiotics for Infants and Women Product Portfolio

6.8.5 Synbio Tech Recent Developments/Updates

6.9 Kerry Group

6.9.1 Kerry Group Company Information

6.9.2 Kerry Group Description and Business Overview

6.9.3 Kerry Group Probiotics for Infants and Women Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Kerry Group Probiotics for Infants and Women Product Portfolio

6.9.5 Kerry Group Recent Developments/Updates

6.10 Nestle

6.10.1 Nestle Company Information

6.10.2 Nestle Description and Business Overview

6.10.3 Nestle Probiotics for Infants and Women Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 Nestle Probiotics for Infants and Women Product Portfolio

6.10.5 Nestle Recent Developments/Updates

6.11 Yakult

6.11.1 Yakult Company Information

6.11.2 Yakult Description and Business Overview

6.11.3 Yakult Probiotics for Infants and Women Sales, Revenue, and Gross Margin (2021–2026)

6.11.4 Yakult Probiotics for Infants and Women Product Portfolio

6.11.5 Yakult Recent Developments/Updates

6.12 Sabinsa

6.12.1 Sabinsa Company Information

6.12.2 Sabinsa Description and Business Overview

6.12.3 Sabinsa Probiotics for Infants and Women Sales, Revenue, and Gross Margin (2021–2026)

6.12.4 Sabinsa Probiotics for Infants and Women Product Portfolio

6.12.5 Sabinsa Recent Developments/Updates

6.13 Evivo

6.13.1 Evivo Company Information

6.13.2 Evivo Description and Business Overview

6.13.3 Evivo Probiotics for Infants and Women Sales, Revenue, and Gross Margin (2021–2026)

6.13.4 Evivo Probiotics for Infants and Women Product Portfolio

6.13.5 Evivo Recent Developments/Updates

6.14 AB-Biotics

6.14.1 AB-Biotics Company Information

6.14.2 AB-Biotics Description and Business Overview

6.14.3 AB-Biotics Probiotics for Infants and Women Sales, Revenue, and Gross Margin (2021–2026)

6.14.4 AB-Biotics Probiotics for Infants and Women Product Portfolio

6.14.5 AB-Biotics Recent Developments/Updates

6.15 Bioflag Group

6.15.1 Bioflag Group Company Information

6.15.2 Bioflag Group Description and Business Overview

6.15.3 Bioflag Group Probiotics for Infants and Women Sales, Revenue, and Gross Margin (2021–2026)

6.15.4 Bioflag Group Probiotics for Infants and Women Product Portfolio

6.15.5 Bioflag Group Recent Developments/Updates

6.16 Beijing Scitop Bio-tech

6.16.1 Beijing Scitop Bio-tech Company Information

6.16.2 Beijing Scitop Bio-tech Description and Business Overview

6.16.3 Beijing Scitop Bio-tech Probiotics for Infants and Women Sales, Revenue, and Gross Margin (2021–2026)

6.16.4 Beijing Scitop Bio-tech Probiotics for Infants and Women Product Portfolio

6.16.5 Beijing Scitop Bio-tech Recent Developments/Updates

6.17 Hebei Yiran Biological Technology

6.17.1 Hebei Yiran Biological Technology Company Information

6.17.2 Hebei Yiran Biological Technology Description and Business Overview

6.17.3 Hebei Yiran Biological Technology Probiotics for Infants and Women Sales, Revenue, and Gross Margin (2021–2026)

6.17.4 Hebei Yiran Biological Technology Probiotics for Infants and Women Product Portfolio

6.17.5 Hebei Yiran Biological Technology Recent Developments/Updates

7.1 Probiotics for Infants and Women Industry Chain Analysis

7.2 Probiotics for Infants and Women Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Probiotics for Infants and Women Production Mode & Process Analysis

7.4 Probiotics for Infants and Women Sales and Marketing

7.4.1 Probiotics for Infants and Women Sales Channels

7.4.2 Probiotics for Infants and Women Distributors

7.5 Probiotics for Infants and Women Customer Analysis

8.1 Probiotics for Infants and Women Industry Trends

8.2 Probiotics for Infants and Women Market Drivers

8.3 Probiotics for Infants and Women Market Challenges

8.4 Probiotics for Infants and Women Market Restraints

8.5 Impact of U.S. Tariffs

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

 Table 1. Global Probiotics for Infants and Women Market Value by Type (US$ Million), 2025 vs 2032

 Table 2. Global Probiotics for Infants and Women Market Value by Application (US$ Million), 2025 vs 2032

 Table 3. Global Probiotics for Infants and Women Market Competitive Situation by Manufacturers in 2025

 Table 4. Global Probiotics for Infants and Women Sales (Tons) of Key Manufacturers (2021–2026)

 Table 5. Global Probiotics for Infants and Women Sales Market Share by Manufacturers (2021–2026)

 Table 6. Global Probiotics for Infants and Women Revenue (US$ Million) by Manufacturers (2021–2026)

 Table 7. Global Probiotics for Infants and Women Revenue Share by Manufacturers (2021–2026)

 Table 8. Global Market Probiotics for Infants and Women Average Price (US$/kg) of Key Manufacturers (2021–2026)

 Table 9. Global Key Players of Probiotics for Infants and Women, Industry Ranking, 2023 vs 2024 vs 2025

 Table 10. Global Key Manufacturers of Probiotics for Infants and Women, Manufacturing Sites and Headquarters

 Table 11. Global Key Manufacturers of Probiotics for Infants and Women, Product Types and Applications

 Table 12. Global Key Manufacturers of Probiotics for Infants and Women, Date of Entry into the Industry

 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

 Table 14. Global Probiotics for Infants and Women Companies by Tier (Tier 1, Tier 2, Tier 3), based on Probiotics for Infants and Women Revenue, 2025

 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

 Table 16. Global Probiotics for Infants and Women Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

 Table 17. Global Probiotics for Infants and Women Sales by Region (Tons), 2021–2026

 Table 18. Global Probiotics for Infants and Women Sales Market Share by Region (2021–2026)

 Table 19. Global Probiotics for Infants and Women Sales by Region (Tons), 2027–2032

 Table 20. Global Probiotics for Infants and Women Sales Market Share by Region (2027–2032)

 Table 21. Global Probiotics for Infants and Women Revenue by Region (US$ Million), 2021–2026

 Table 22. Global Probiotics for Infants and Women Revenue Market Share by Region (2021–2026)

 Table 23. Global Probiotics for Infants and Women Revenue by Region (US$ Million), 2027–2032

 Table 24. Global Probiotics for Infants and Women Revenue Market Share by Region (2027–2032)

 Table 25. North America Probiotics for Infants and Women Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 26. North America Probiotics for Infants and Women Sales by Country (Tons), 2021–2026

 Table 27. North America Probiotics for Infants and Women Sales by Country (Tons), 2027–2032

 Table 28. North America Probiotics for Infants and Women Revenue by Country (US$ Million), 2021–2026

 Table 29. North America Probiotics for Infants and Women Revenue by Country (US$ Million), 2027–2032

 Table 30. Europe Probiotics for Infants and Women Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 31. Europe Probiotics for Infants and Women Sales by Country (Tons), 2021–2026

 Table 32. Europe Probiotics for Infants and Women Sales by Country (Tons), 2027–2032

 Table 33. Europe Probiotics for Infants and Women Revenue by Country (US$ Million), 2021–2026

 Table 34. Europe Probiotics for Infants and Women Revenue by Country (US$ Million), 2027–2032

 Table 35. Asia Pacific Probiotics for Infants and Women Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

 Table 36. Asia Pacific Probiotics for Infants and Women Sales by Region (Tons), 2021–2026

 Table 37. Asia Pacific Probiotics for Infants and Women Sales by Region (Tons), 2027–2032

 Table 38. Asia Pacific Probiotics for Infants and Women Revenue by Region (US$ Million), 2021–2026

 Table 39. Asia Pacific Probiotics for Infants and Women Revenue by Region (US$ Million), 2027–2032

 Table 40. Latin America Probiotics for Infants and Women Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 41. Latin America Probiotics for Infants and Women Sales by Country (Tons), 2021–2026

 Table 42. Latin America Probiotics for Infants and Women Sales by Country (Tons), 2027–2032

 Table 43. Latin America Probiotics for Infants and Women Revenue by Country (US$ Million), 2021–2026

 Table 44. Latin America Probiotics for Infants and Women Revenue by Country (US$ Million), 2027–2032

 Table 45. Middle East and Africa Probiotics for Infants and Women Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 46. Middle East and Africa Probiotics for Infants and Women Sales by Country (Tons), 2021–2026

 Table 47. Middle East and Africa Probiotics for Infants and Women Sales by Country (Tons), 2027–2032

 Table 48. Middle East and Africa Probiotics for Infants and Women Revenue by Country (US$ Million), 2021–2026

 Table 49. Middle East and Africa Probiotics for Infants and Women Revenue by Country (US$ Million), 2027–2032

 Table 50. Global Probiotics for Infants and Women Sales (Tons) by Type (2021–2026)

 Table 51. Global Probiotics for Infants and Women Sales (Tons) by Type (2027–2032)

 Table 52. Global Probiotics for Infants and Women Sales Market Share by Type (2021–2026)

 Table 53. Global Probiotics for Infants and Women Sales Market Share by Type (2027–2032)

 Table 54. Global Probiotics for Infants and Women Revenue (US$ Million) by Type (2021–2026)

 Table 55. Global Probiotics for Infants and Women Revenue (US$ Million) by Type (2027–2032)

 Table 56. Global Probiotics for Infants and Women Revenue Market Share by Type (2021–2026)

 Table 57. Global Probiotics for Infants and Women Revenue Market Share by Type (2027–2032)

 Table 58. Global Probiotics for Infants and Women Price (US$/kg) by Type (2021–2026)

 Table 59. Global Probiotics for Infants and Women Price (US$/kg) by Type (2027–2032)

 Table 60. Global Probiotics for Infants and Women Sales (Tons) by Application (2021–2026)

 Table 61. Global Probiotics for Infants and Women Sales (Tons) by Application (2027–2032)

 Table 62. Global Probiotics for Infants and Women Sales Market Share by Application (2021–2026)

 Table 63. Global Probiotics for Infants and Women Sales Market Share by Application (2027–2032)

 Table 64. Global Probiotics for Infants and Women Revenue (US$ Million) by Application (2021–2026)

 Table 65. Global Probiotics for Infants and Women Revenue (US$ Million) by Application (2027–2032)

 Table 66. Global Probiotics for Infants and Women Revenue Market Share by Application (2021–2026)

 Table 67. Global Probiotics for Infants and Women Revenue Market Share by Application (2027–2032)

 Table 68. Global Probiotics for Infants and Women Price (US$/kg) by Application (2021–2026)

 Table 69. Global Probiotics for Infants and Women Price (US$/kg) by Application (2027–2032)

 Table 70. DuPont Company Information

 Table 71. DuPont Description and Business Overview

 Table 72. DuPont Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

 Table 73. DuPont Probiotics for Infants and Women Product

 Table 74. DuPont Recent Developments/Updates

 Table 75. Novonesis Company Information

 Table 76. Novonesis Description and Business Overview

 Table 77. Novonesis Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

 Table 78. Novonesis Probiotics for Infants and Women Product

 Table 79. Novonesis Recent Developments/Updates

 Table 80. Lallemand Company Information

 Table 81. Lallemand Description and Business Overview

 Table 82. Lallemand Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

 Table 83. Lallemand Probiotics for Infants and Women Product

 Table 84. Lallemand Recent Developments/Updates

 Table 85. BioGaia Company Information

 Table 86. BioGaia Description and Business Overview

 Table 87. BioGaia Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

 Table 88. BioGaia Probiotics for Infants and Women Product

 Table 89. BioGaia Recent Developments/Updates

 Table 90. Probi Company Information

 Table 91. Probi Description and Business Overview

 Table 92. Probi Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

 Table 93. Probi Probiotics for Infants and Women Product

 Table 94. Probi Recent Developments/Updates

 Table 95. Biosearch Life Company Information

 Table 96. Biosearch Life Description and Business Overview

 Table 97. Biosearch Life Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

 Table 98. Biosearch Life Probiotics for Infants and Women Product

 Table 99. Biosearch Life Recent Developments/Updates

 Table 100. Morinaga Milk Industry Company Information

 Table 101. Morinaga Milk Industry Description and Business Overview

 Table 102. Morinaga Milk Industry Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

 Table 103. Morinaga Milk Industry Probiotics for Infants and Women Product

 Table 104. Morinaga Milk Industry Recent Developments/Updates

 Table 105. Synbio Tech Company Information

 Table 106. Synbio Tech Description and Business Overview

 Table 107. Synbio Tech Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

 Table 108. Synbio Tech Probiotics for Infants and Women Product

 Table 109. Synbio Tech Recent Developments/Updates

 Table 110. Kerry Group Company Information

 Table 111. Kerry Group Description and Business Overview

 Table 112. Kerry Group Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

 Table 113. Kerry Group Probiotics for Infants and Women Product

 Table 114. Kerry Group Recent Developments/Updates

 Table 115. Nestle Company Information

 Table 116. Nestle Description and Business Overview

 Table 117. Nestle Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

 Table 118. Nestle Probiotics for Infants and Women Product

 Table 119. Nestle Recent Developments/Updates

 Table 120. Yakult Company Information

 Table 121. Yakult Description and Business Overview

 Table 122. Yakult Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

 Table 123. Yakult Probiotics for Infants and Women Product

 Table 124. Yakult Recent Developments/Updates

 Table 125. Sabinsa Company Information

 Table 126. Sabinsa Description and Business Overview

 Table 127. Sabinsa Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

 Table 128. Sabinsa Probiotics for Infants and Women Product

 Table 129. Sabinsa Recent Developments/Updates

 Table 130. Evivo Company Information

 Table 131. Evivo Description and Business Overview

 Table 132. Evivo Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

 Table 133. Evivo Probiotics for Infants and Women Product

 Table 134. Evivo Recent Developments/Updates

 Table 135. AB-Biotics Company Information

 Table 136. AB-Biotics Description and Business Overview

 Table 137. AB-Biotics Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

 Table 138. AB-Biotics Probiotics for Infants and Women Product

 Table 139. AB-Biotics Recent Developments/Updates

 Table 140. Bioflag Group Company Information

 Table 141. Bioflag Group Description and Business Overview

 Table 142. Bioflag Group Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

 Table 143. Bioflag Group Probiotics for Infants and Women Product

 Table 144. Bioflag Group Recent Developments/Updates

 Table 145. Beijing Scitop Bio-tech Company Information

 Table 146. Beijing Scitop Bio-tech Description and Business Overview

 Table 147. Beijing Scitop Bio-tech Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

 Table 148. Beijing Scitop Bio-tech Probiotics for Infants and Women Product

 Table 149. Beijing Scitop Bio-tech Recent Developments/Updates

 Table 150. Hebei Yiran Biological Technology Company Information

 Table 151. Hebei Yiran Biological Technology Description and Business Overview

 Table 152. Hebei Yiran Biological Technology Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

 Table 153. Hebei Yiran Biological Technology Probiotics for Infants and Women Product

 Table 154. Hebei Yiran Biological Technology Recent Developments/Updates

 Table 155. Key Raw Materials Lists

 Table 156. Raw Materials Key Suppliers Lists

 Table 157. Probiotics for Infants and Women Distributors List

 Table 158. Probiotics for Infants and Women Customers List

 Table 159. Probiotics for Infants and Women Market Trends

 Table 160. Probiotics for Infants and Women Market Drivers

 Table 161. Probiotics for Infants and Women Market Challenges

 Table 162. Probiotics for Infants and Women Market Restraints

 Table 163. Research Programs/Design for This Report

 Table 164. Key Data Information from Secondary Sources

 Table 165. Key Data Information from Primary Sources

 Table 166. Authors List of This Report

List of Figures

 Figure 1. Product Picture of Probiotics for Infants and Women

 Figure 2. Global Probiotics for Infants and Women Market Value by Type (US$ Million), 2021–2032

 Figure 3. Global Probiotics for Infants and Women Market Share by Type: 2025 & 2032

 Figure 4. Lactobacillus Product Picture

 Figure 5. Bifidobacterium Product Picture

 Figure 6. Others Product Picture

 Figure 7. Global Probiotics for Infants and Women Market Value by Application (US$ Million), 2021–2032

 Figure 8. Global Probiotics for Infants and Women Market Share by Application: 2025 & 2032

 Figure 9. Infant

 Figure 10. Women

 Figure 11. Global Probiotics for Infants and Women Revenue, (US$ Million), 2021 vs 2025 vs 2032

 Figure 12. Global Probiotics for Infants and Women Market Size (US$ Million), 2021–2032

 Figure 13. Global Probiotics for Infants and Women Sales (Tons), 2021–2032

 Figure 14. Global Probiotics for Infants and Women Average Price (US$/kg), 2021–2032

 Figure 15. Probiotics for Infants and Women Report Years Considered

 Figure 16. Probiotics for Infants and Women Sales Share by Manufacturers in 2025

 Figure 17. Global Probiotics for Infants and Women Revenue Share by Manufacturers in 2025

 Figure 18. Top 5 and Top 10 Global Probiotics for Infants and Women Players: Market Share by Revenue in Probiotics for Infants and Women in 2025

 Figure 19. Probiotics for Infants and Women Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

 Figure 20. Global Probiotics for Infants and Women Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

 Figure 21. North America Probiotics for Infants and Women Sales Market Share by Country (2021–2032)

 Figure 22. North America Probiotics for Infants and Women Revenue Market Share by Country (2021–2032)

 Figure 23. United States Probiotics for Infants and Women Revenue Growth Rate (US$ Million), 2021–2032

 Figure 24. Canada Probiotics for Infants and Women Revenue Growth Rate (US$ Million), 2021–2032

 Figure 25. Europe Probiotics for Infants and Women Sales Market Share by Country (2021–2032)

 Figure 26. Europe Probiotics for Infants and Women Revenue Market Share by Country (2021–2032)

 Figure 27. Germany Probiotics for Infants and Women Revenue Growth Rate (US$ Million), 2021–2032

 Figure 28. France Probiotics for Infants and Women Revenue Growth Rate (US$ Million), 2021–2032

 Figure 29. U.K. Probiotics for Infants and Women Revenue Growth Rate (US$ Million), 2021–2032

 Figure 30. Italy Probiotics for Infants and Women Revenue Growth Rate (US$ Million), 2021–2032

 Figure 31. Russia Probiotics for Infants and Women Revenue Growth Rate (US$ Million), 2021–2032

 Figure 32. Asia Pacific Probiotics for Infants and Women Sales Market Share by Region (2021–2032)

 Figure 33. Asia Pacific Probiotics for Infants and Women Revenue Market Share by Region (2021–2032)

 Figure 34. China Probiotics for Infants and Women Revenue Growth Rate (US$ Million), 2021–2032

 Figure 35. Japan Probiotics for Infants and Women Revenue Growth Rate (US$ Million), 2021–2032

 Figure 36. South Korea Probiotics for Infants and Women Revenue Growth Rate (US$ Million), 2021–2032

 Figure 37. India Probiotics for Infants and Women Revenue Growth Rate (US$ Million), 2021–2032

 Figure 38. Australia Probiotics for Infants and Women Revenue Growth Rate (US$ Million), 2021–2032

 Figure 39. China Taiwan Probiotics for Infants and Women Revenue Growth Rate (US$ Million), 2021–2032

 Figure 40. Indonesia Probiotics for Infants and Women Revenue Growth Rate (US$ Million), 2021–2032

 Figure 41. Thailand Probiotics for Infants and Women Revenue Growth Rate (US$ Million), 2021–2032

 Figure 42. Malaysia Probiotics for Infants and Women Revenue Growth Rate (US$ Million), 2021–2032

 Figure 43. Latin America Probiotics for Infants and Women Sales Market Share by Country (2021–2032)

 Figure 44. Latin America Probiotics for Infants and Women Revenue Market Share by Country (2021–2032)

 Figure 45. Mexico Probiotics for Infants and Women Revenue Growth Rate (US$ Million), 2021–2032

 Figure 46. Brazil Probiotics for Infants and Women Revenue Growth Rate (US$ Million), 2021–2032

 Figure 47. Argentina Probiotics for Infants and Women Revenue Growth Rate (US$ Million), 2021–2032

 Figure 48. Colombia Probiotics for Infants and Women Revenue Growth Rate (US$ Million), 2021–2032

 Figure 49. Middle East and Africa Probiotics for Infants and Women Sales Market Share by Country (2021–2032)

 Figure 50. Middle East and Africa Probiotics for Infants and Women Revenue Market Share by Country (2021–2032)

 Figure 51. Turkey Probiotics for Infants and Women Revenue Growth Rate (US$ Million), 2021–2032

 Figure 52. Saudi Arabia Probiotics for Infants and Women Revenue Growth Rate (US$ Million), 2021–2032

 Figure 53. UAE Probiotics for Infants and Women Revenue Growth Rate (US$ Million), 2021–2032

 Figure 54. Global Sales Market Share of Probiotics for Infants and Women by Type (2021–2032)

 Figure 55. Global Revenue Market Share of Probiotics for Infants and Women by Type (2021–2032)

 Figure 56. Global Probiotics for Infants and Women Price (US$/kg) by Type (2021–2032)

 Figure 57. Global Sales Market Share of Probiotics for Infants and Women by Application (2021–2032)

 Figure 58. Global Revenue Market Share of Probiotics for Infants and Women by Application (2021–2032)

 Figure 59. Global Probiotics for Infants and Women Price (US$/kg) by Application (2021–2032)

 Figure 60. Probiotics for Infants and Women Value Chain

 Figure 61. Channels of Distribution (Direct Vs Distribution)

 Figure 62. Bottom-up and Top-down Approaches for This Report

 Figure 63. Data Triangulation

 Figure 64. Key Executives Interviewed